Literature DB >> 25845698

Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study.

Carla Piano1,2, Anna Losurdo3, Giacomo Della Marca3, Marcella Solito1, Giovanna Calandra-Buonaura2, Federica Provini2, Anna Rita Bentivoglio1, Pietro Cortelli2.   

Abstract

STUDY
OBJECTIVES: To evaluate the sleep pattern and the motor activity during sleep in a cohort of patients affected by Huntington disease (HD).
DESIGN: Cross-sectional cohort study.
SETTING: Sleep laboratory. PATIENTS: Thirty HD patients, 16 women and 14 men (mean age 57.3 ± 12.2 y); 30 matched healthy controls (mean age 56.5 ± 11.8 y).
INTERVENTIONS: Subjective sleep evaluation: Epworth Sleepiness Scale (ESS); Berlin's Questionnaire, interview for restless legs syndrome (RLS), questionnaire for REM sleep behavior disorder (RBD). Clinical evaluation: disease duration, clinical severity (unified Huntington disease motor rating scale [UHDMRS]), genetic tests. Laboratory-based full-night attended video-polysomnography (V-PSG). MEASUREMENTS AND
RESULTS: The duration of the disease was 9.4 ± 4.4 y, UHMDRS score was 55.5 ± 23.4, CAG repeats were 44.3 ± 4.1. Body mass index was 21.9 ± 4.0 kg/m(2). No patients or caregivers reported poor sleep quality. Two patients reported symptoms of RLS. Eight patients had an ESS score ≥ 9. Eight patients had high risk of obstructive sleep apnea. At the RBD questionnaire, two patients had a pathological score. HD patients, compared to controls, showed shorter sleep, reduced sleep efficiency index, and increased arousals and awakenings. Four patients presented with sleep disordered breathing (SDB). Periodic limb movements (PLMs) during wake and sleep were observed in all patients. No episode of RBD was observed in the V-PSG recordings, and no patients showed rapid eye movement (REM) sleep without atonia. The disease duration correlated with ESS score (P < 0.02). UHMDRS correlated positively with the ESS score (P < 0.005), and negatively with the percentage of REM sleep.
CONCLUSIONS: Patients with Huntington disease showed a severe sleep disruption and a high prevalence of periodic limb movements, but no evidence of sleep disordered breathing or REM sleep behavior disorder.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  Huntington disease; REM eye movement sleep behavior disorder; periodic limb movements; polysomnography; sleep

Mesh:

Year:  2015        PMID: 25845698      PMCID: PMC4531417          DOI: 10.5665/sleep.4996

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  33 in total

1.  Effects of caudate nuclei or frontal cortex ablations in cats. II. Sleep-wakefulness, EEG, and motor activity.

Authors:  J R Villablanca; R J Marcus; C E Olmstead
Journal:  Exp Neurol       Date:  1976-10       Impact factor: 5.330

2.  Changes in nocturnal sleep in Huntington's and Parkinson's disease.

Authors:  W Emser; M Brenner; T Stober; K Schimrigk
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

3.  Spinal neuronal inhibition and EEG synchrony by electrical stimulation in subcortical forebrain regions of the cat.

Authors:  J Siegel; C R Morton; J Sandkühler; H M Xiao; M Zimmermann
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

4.  Skeletal and automatic inhibition from low-frequency electrical stimulation of the cat's brain.

Authors:  R C Wilcott
Journal:  Neuropsychologia       Date:  1974-10       Impact factor: 3.139

5.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics.

Authors:  Suk-Hoon Kang; In-Young Yoon; Sang Don Lee; Ji Won Han; Tae Hui Kim; Ki Woong Kim
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

Review 7.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

Review 8.  The epidemiology of Huntington's disease.

Authors:  P S Harper
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

9.  Brain morphology and sleep EEG in patients with Huntington's disease.

Authors:  M Wiegand; A A Möller; W Schreiber; C Lauer; J C Krieg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

10.  Nocturnal sleep in Huntington's disease.

Authors:  M Wiegand; A A Möller; C J Lauer; S Stolz; W Schreiber; M Dose; J C Krieg
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

View more
  18 in total

1.  Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.

Authors:  Ye Zhang; Rong Ren; Linghui Yang; Junying Zhou; Yun Li; Jie Shi; Lin Lu; Larry D Sanford; Xiangdong Tang
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

2.  An EEG Investigation of Sleep Homeostasis in Healthy and CLN5 Batten Disease Affected Sheep.

Authors:  Nicholas Perentos; Amadeu Q Martins; Robin J M Cumming; Nadia L Mitchell; David N Palmer; Stephen J Sawiak; A Jennifer Morton
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

Review 3.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

4.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 5.  RBD and Neurodegenerative Diseases.

Authors:  Haiyang Jiang; Jinsha Huang; Yan Shen; Shiyi Guo; Luxi Wang; Chao Han; Ling Liu; Kai Ma; Yun Xia; Jie Li; Xiaoyun Xu; Nian Xiong; Tao Wang
Journal:  Mol Neurobiol       Date:  2016-03-31       Impact factor: 5.590

6.  The sleep and circadian problems of Huntington's disease: when, why and their importance.

Authors:  Z Voysey; S V Fazal; A S Lazar; R A Barker
Journal:  J Neurol       Date:  2020-12-23       Impact factor: 4.849

7.  Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.

Authors:  Sandor Kantor; Janos Varga; Shreya Kulkarni; A Jennifer Morton
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Assessment of Sleep Spindle Density among Genetically Positive Spinocerebellar Ataxias Types 1, 2, and 3 Patients.

Authors:  Doniparthi Venkata Seshagiri; Ragasudha Botta; Arun Sasidharan; Pramod Kumar Pal; Sanjeev Jain; Ravi Yadav; Bindu M Kutty
Journal:  Ann Neurosci       Date:  2018-03-08

9.  Sleep deficits but no metabolic deficits in premanifest Huntington's disease.

Authors:  Alpar S Lazar; Francesca Panin; Anna O G Goodman; Stanley E Lazic; Zsolt I Lazar; Sarah L Mason; Lorraine Rogers; Peter R Murgatroyd; Laura P E Watson; Priya Singh; Beth Borowsky; John M Shneerson; Roger A Barker
Journal:  Ann Neurol       Date:  2015-08-21       Impact factor: 10.422

10.  Altered Wnt Signaling Pathway in Cognitive Impairment Caused by Chronic Intermittent Hypoxia: Focus on Glycogen Synthase Kinase-3β and β-catenin.

Authors:  Yue-Ying Pan; Yan Deng; Sheng Xie; Zhi-Hua Wang; Yu Wang; Jie Ren; Hui-Guo Liu
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.